Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
4.270
-0.230 (-5.11%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lyra Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -32.95 | -93.44 | -62.68 | -55.28 | -43.51 | -22.13 | |
| Depreciation & Amortization | 0.51 | 0.47 | 0.28 | 1.07 | 1 | 0.1 | |
| Other Amortization | - | 0.14 | - | - | - | - | |
| Loss (Gain) From Sale of Assets | -0.01 | - | - | - | - | -0.05 | |
| Asset Writedown & Restructuring Costs | - | 24.72 | 1.59 | 1.32 | - | - | |
| Loss (Gain) From Sale of Investments | -0.27 | -2.28 | -3.5 | -0.49 | - | - | |
| Stock-Based Compensation | 3.71 | 6.72 | 5.89 | 5.45 | 2.77 | 1.81 | |
| Change in Accounts Payable | -1.73 | -1.89 | 0.45 | -2.41 | 2.35 | 0.35 | |
| Change in Unearned Revenue | -0.6 | -1.53 | -1.56 | 3.64 | 11.72 | - | |
| Change in Other Net Operating Assets | -2.81 | -2.93 | -3.78 | 3.33 | -0.14 | -1.22 | |
| Operating Cash Flow | -34.15 | -70.01 | -63.3 | -43.39 | -25.82 | -21.14 | |
| Capital Expenditures | 0.04 | -2.34 | -1.05 | -0.16 | -3.39 | -1.78 | |
| Investment in Securities | 28.07 | 82.64 | -11.54 | -64.84 | - | - | |
| Investing Cash Flow | 28.13 | 80.31 | -12.58 | -65.01 | -3.39 | -1.78 | |
| Issuance of Common Stock | 5 | 8.82 | 69.35 | 100.5 | 0.6 | 59.9 | |
| Other Financing Activities | -0.73 | -0.29 | -3.65 | -4.25 | -0.25 | -2.59 | |
| Financing Cash Flow | 4.27 | 8.53 | 65.69 | 96.26 | 0.36 | 87.7 | |
| Net Cash Flow | -1.74 | 18.83 | -10.2 | -12.13 | -28.85 | 64.79 | |
| Free Cash Flow | -34.11 | -72.35 | -64.35 | -43.55 | -29.21 | -22.92 | |
| Free Cash Flow Margin | -5684.50% | -4716.36% | -4130.36% | -3195.08% | -10247.37% | - | |
| Free Cash Flow Per Share | -23.74 | -55.56 | -64.60 | -72.02 | -112.45 | -133.40 | |
| Levered Free Cash Flow | -20.3 | -39 | -33.73 | -33.03 | -14.45 | -15.17 | |
| Unlevered Free Cash Flow | -20.3 | -39.14 | -33.73 | -33.03 | -14.45 | -15.17 | |
| Change in Working Capital | -5.15 | -6.35 | -4.89 | 4.56 | 13.92 | -0.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.